糖尿病患者相关胰岛素使用不足的成本问题。
Cost-Related Insulin Underuse Among Patients With Diabetes.
机构信息
Yale College, New Haven, Connecticut.
Yale School of Medicine, New Haven, Connecticut.
出版信息
JAMA Intern Med. 2019 Jan 1;179(1):112-114. doi: 10.1001/jamainternmed.2018.5008.
Abstract
This survey study examines the association of higher insulin costs with nonadherence in patients with diabetes.
摘要
本调查研究考察了胰岛素费用较高与糖尿病患者不遵医嘱之间的关联。
相似文献
1
Cost-Related Insulin Underuse Among Patients With Diabetes.糖尿病患者相关胰岛素使用不足的成本问题。
JAMA Intern Med. 2019 Jan 1;179(1):112-114. doi: 10.1001/jamainternmed.2018.5008.
2
Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe.胰岛素装置（FlexPen）与传统瓶/注射器的依从性和医疗成本评估。
Adv Ther. 2010 Feb;27(2):94-104. doi: 10.1007/s12325-010-0009-6. Epub 2010 Mar 26.
3
The market in diabetes.糖尿病市场。
Diabetologia. 2006 Feb;49(2):247-52. doi: 10.1007/s00125-005-0108-0.
4
Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.医疗补助计划覆盖的2型糖尿病患者开始胰岛素笔治疗后的医疗费用及药物依从性：一项回顾性数据库分析
Clin Ther. 2007 Jun;29(6 Pt 1):1294-305. doi: 10.1016/j.clinthera.2007.07.007.
5
Association of Out-of-Pocket Spending With Insulin Adherence in Medicare Part D.医疗保险处方药中外购支出与胰岛素依从性的关联。
JAMA Netw Open. 2021 Jan 4;4(1):e2033988. doi: 10.1001/jamanetworkopen.2020.33988.
6
Small daily doses of insulin: wasting money?每日小剂量胰岛素：在浪费钱吗？
J Diabetes Sci Technol. 2012 Jan 1;6(1):225. doi: 10.1177/193229681200600132.
7
[Insulin. A comparison of commercial preparations].[胰岛素。市售制剂的比较]
Med Monatsschr Pharm. 2006 Mar;29(3):97-100.
8
Healthcare reform in diabetes: more ranting about a broken system.糖尿病医疗改革：对一个破败系统的更多抱怨。
Diabetes Technol Ther. 2013 Mar;15(3):212-3. doi: 10.1089/dia.2013.0019. Epub 2013 Mar 4.
9
Comparison of medication adherence in diabetes mellitus patients on human versus analogue insulins.使用人胰岛素与胰岛素类似物的糖尿病患者药物依从性比较。
Expert Opin Drug Saf. 2017 Feb;16(2):133-137. doi: 10.1080/14740338.2017.1273346. Epub 2016 Dec 26.
10
Comparing insulin vials to pens--comparison of charges, not healthcare benefits.胰岛素小瓶与笔式注射器的比较——费用比较，而非医疗效益比较。
J Med Econ. 2013 Oct;16(10):1228-30. doi: 10.3111/13696998.2013.832259. Epub 2013 Sep 5.
引用本文的文献
1
Type 2 Diabetes and Financial Outcomes.2型糖尿病与财务状况
JAMA Netw Open. 2025 Jul 1;8(7):e2523453. doi: 10.1001/jamanetworkopen.2025.23453.
2
Attention-deficit hyperactivity disorder medication shortage in the United States: a qualitative assessment of Reddit posts.美国注意力缺陷多动障碍药物短缺：对Reddit帖子的定性评估
Front Pharmacol. 2025 Jul 7;16:1529115. doi: 10.3389/fphar.2025.1529115. eCollection 2025.
3
Filling Diabetes Medications Through VA or Medicare, or Both: Factors in Decision Making, Challenges, and Informational Needs.通过退伍军人事务部（VA）或医疗保险（Medicare），或两者来获取糖尿病药物：决策因素、挑战及信息需求
J Gen Intern Med. 2025 May 6. doi: 10.1007/s11606-025-09576-6.
4
Evaluation of Pharmacokinetics and Safety of the Biosimilar (B01711) and Insulin Degludec/Insulin Aspart (IDegAsp, Ryzodeg) in Healthy Chinese Adults in a Randomized, Open-Label, Single-Dose, Crossover, Phase I Study.一项随机、开放标签、单剂量、交叉的I期研究中，评估生物类似药（B01711）与德谷胰岛素/门冬胰岛素（IDegAsp，Ryzodeg）在健康中国成年人中的药代动力学和安全性。
Drug Des Devel Ther. 2025 Apr 11;19:2863-2871. doi: 10.2147/DDDT.S500347. eCollection 2025.
5
A Multidisciplinary Approach of Type 1 Diabetes: The Intersection of Technology, Immunotherapy, and Personalized Medicine.1型糖尿病的多学科治疗方法：技术、免疫疗法与个性化医疗的交叉融合
J Clin Med. 2025 Mar 21;14(7):2144. doi: 10.3390/jcm14072144.
6
"Can I afford to live today?" The emotional toll of navigating the healthcare system with type 1 diabetes.“我今天能负担得起生活费用吗？” 1型糖尿病患者在医疗系统中面临的情感负担。
Front Endocrinol (Lausanne). 2025 Mar 24;16:1555265. doi: 10.3389/fendo.2025.1555265. eCollection 2025.
7
Effects of the Part D Senior Savings Model on racial and ethnic disparities in healthcare costs.D部分老年人储蓄模式对医疗保健费用中种族和民族差异的影响。
Curr Med Res Opin. 2025 Mar;41(3):431-440. doi: 10.1080/03007995.2025.2479780. Epub 2025 Mar 31.
8
Insights on Improving Health Insurance Literacy in Diabetes.提高糖尿病患者健康保险素养的见解。
J Clin Endocrinol Metab. 2025 Feb 25;110(Supplement_2):S175-S186. doi: 10.1210/clinem/dgae706.
9
The Association Between Cost-Related Insulin Rationing and Health Care Utilization in U.S. Adults With Diabetes.美国成年糖尿病患者中与费用相关的胰岛素配给与医疗保健利用之间的关联
Diabetes Care. 2025 Mar 1;48(3):400-404. doi: 10.2337/dc24-2117.
10
Barriers to WHO prequalification of similar biotherapeutic insulin.阻碍世卫组织预认证类似生物治疗性胰岛素。
Bull World Health Organ. 2024 Nov 1;102(11):795-802. doi: 10.2471/BLT.24.291804. Epub 2024 Sep 25.
本文引用的文献
1
Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013.美国降糖药物的支出与价格：2002 - 2013年
JAMA. 2016 Apr 5;315(13):1400-2. doi: 10.1001/jama.2016.0126.
2
Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010.2000年至2010年2型糖尿病患者胰岛素的使用情况及自付费用
JAMA. 2014 Jun 11;311(22):2331-3. doi: 10.1001/jama.2014.6316.
3
Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.美国和加拿大与费用相关的处方不依从性：使用2007年七国国际卫生政策调查进行的系统层面比较。
Clin Ther. 2009 Jan;31(1):213-9. doi: 10.1016/j.clinthera.2009.01.006.
4
Cohort Profile: The Diabetes Study of Northern California (DISTANCE)--objectives and design of a survey follow-up study of social health disparities in a managed care population.队列简介：北加利福尼亚糖尿病研究（DISTANCE）——一项针对管理式医疗人群社会健康差异的调查随访研究的目标与设计
Int J Epidemiol. 2009 Feb;38(1):38-47. doi: 10.1093/ije/dyn040. Epub 2008 Mar 7.
5
Problems paying out-of-pocket medication costs among older adults with diabetes.糖尿病老年患者自付药费的问题。
Diabetes Care. 2004 Feb;27(2):384-91. doi: 10.2337/diacare.27.2.384.
Zotero 插件